Related references
Note: Only part of the references are listed.Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer
Mingyang Liu et al.
GASTROENTEROLOGY (2021)
A TNFR2-hnRNPK Axis Promotes Primary Liver Cancer Development via Activation of YAP Signaling in Hepatic Progenitor Cells
Yan Meng et al.
CANCER RESEARCH (2021)
Interferon-γ induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation
Man Yu et al.
MOLECULAR CELL (2021)
YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation
Lizhi He et al.
ELIFE (2021)
Induction of AP-1 by YAP/TAZ contributes to cell proliferation and organ growth
Ja Hyun Koo et al.
GENES & DEVELOPMENT (2020)
YAP-Mediated Recruitment of YY1 and EZH2 Represses Transcription of Key Cell-Cycle Regulators
Sany Hoxha et al.
CANCER RESEARCH (2020)
MST4 kinase suppresses gastric tumorigenesis by limiting YAP activation via a non-canonical pathway
Liwei An et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
IKBKE activity enhances AR levels in advanced prostate cancer via modulation of the Hippo pathway
Alex Bainbridge et al.
NUCLEIC ACIDS RESEARCH (2020)
Genome-wide cooperation of EMT transcription factor ZEB1 with YAP and AP-1 in breast cancer
Nora Feldker et al.
EMBO JOURNAL (2020)
Selective Inhibition of STRN3-Containing PP2A Phosphatase Restores Hippo Tumor-Suppressor Activity in Gastric Cancer
Yang Tang et al.
CANCER CELL (2020)
YAP and AP-1 Cooperate to Initiate Pancreatic Cancer Development from Ductal Cells in Mice
Jaeoh Park et al.
CANCER RESEARCH (2020)
A Regulation Loop between YAP and NR4A1 Balances Cell Proliferation and Apoptosis
Lingli He et al.
CELL REPORTS (2020)
SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression
Zhijie Zhang et al.
THERANOSTICS (2020)
A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK
Xiaodong Feng et al.
CANCER CELL (2019)
A Non-canonical Role of YAP/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer
Chi Zhu et al.
MOLECULAR CELL (2019)
STRIPAK integrates upstream signals to initiate the Hippo kinase cascade
Rui Chen et al.
NATURE CELL BIOLOGY (2019)
Architecture, substructures, and dynamic assembly of STRIPAK complexes in Hippo signaling
Yang Tang et al.
CELL DISCOVERY (2019)
SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes Tumorigenesis
Lan Fang et al.
CANCER CELL (2018)
PRDM4 mediates YAP-induced cell invasion by activating leukocyte-specific integrin beta 2 expression
Huan Liu et al.
EMBO REPORTS (2018)
Targeting IRF3 as a YAP agonist therapy against gastric cancer
Shi Jiao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
SKP2-and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity
Fan Yao et al.
NATURE COMMUNICATIONS (2018)
YAP-TEAD signaling promotes basal cell carcinoma development via a c-JUN/AP1 axis
Dejan Maglic et al.
EMBO JOURNAL (2018)
RAP2 mediates mechanoresponses of the Hippo pathway
Zhipeng Meng et al.
NATURE (2018)
A feed forward loop enforces YAP/TAZ signaling during tumorigenesis
Mandeep K. Gill et al.
NATURE COMMUNICATIONS (2018)
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells
Dana Elster et al.
NATURE COMMUNICATIONS (2018)
The SWI/SNF complex is a mechanoregulated inhibitor of YAP and TAZ
Lei Chang et al.
NATURE (2018)
Osmotic stress-induced phosphorylation by NLK at Ser128 activates YAP
Audrey W. Hong et al.
EMBO REPORTS (2017)
Yes-Associated Protein/TEA Domain Family Member and Hepatocyte Nuclear Factor 4-Alpha (HNF4α) Repress Reciprocally to Regulate Hepatocarcinogenesis in Rats and Mice
Wang-Yu Cai et al.
HEPATOLOGY (2017)
RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3
J-W Jang et al.
ONCOGENE (2017)
Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation
Changmin Peng et al.
MOLECULAR CELL (2017)
Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation
Kimberly C. Lin et al.
NATURE CELL BIOLOGY (2017)
CRB3 regulates contact inhibition by activating the Hippo pathway in mammary epithelial cells
Xiaona Mao et al.
CELL DEATH & DISEASE (2017)
The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis
Xiao Zhang et al.
NATURE COMMUNICATIONS (2017)
A genome-wide screen identifies YAP/WBP2 interplay conferring growth advantage on human epidermal stem cells
Gernot Walko et al.
NATURE COMMUNICATIONS (2017)
A reciprocal regulatory loop between TAZ/YAP and G-protein Gαs regulates Schwann cell proliferation and myelination
Yaqi Deng et al.
NATURE COMMUNICATIONS (2017)
Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells
Krishna S. Tummala et al.
CELL REPORTS (2017)
Homeostatic Control of Hpo/MST Kinase Activity through Autophosphorylation-Dependent Recruitment of the STRIPAK PP2A Phosphatase Complex
Yonggang Zheng et al.
CELL REPORTS (2017)
Force Triggers YAP Nuclear Entry by Regulating Transport across Nuclear Pores
Alberto Elosegui-Artola et al.
CELL (2017)
RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma
Xu Chen et al.
CANCER CELL (2017)
RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer
Y. Qiao et al.
ONCOGENE (2016)
DLG5 connects cell polarity and Hippo signaling protein networks by linking PAR-1 with MST1/2
Julian Kwan et al.
GENES & DEVELOPMENT (2016)
αE-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway
Peng Li et al.
GENES & DEVELOPMENT (2016)
ZO-2 silencing induces renal hypertrophy through a cell cycle mechanism and the activation of YAP and the mTOR pathway
Alaide Dominguez-Calderon et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
Characterization of Hippo Pathway Components by Gene Inactivation
Steven W. Plouffe et al.
MOLECULAR CELL (2016)
ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types
Waltraut Lehmann et al.
NATURE COMMUNICATIONS (2016)
Zyxin-Siah2-Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways
Biao Ma et al.
NATURE COMMUNICATIONS (2016)
Alternative Wnt Signaling Activates YAP/TAZ
Hyun Woo Park et al.
CELL (2015)
NDR Functions as a Physiological YAP1 Kinase in the Intestinal Epithelium
Lei Zhang et al.
CURRENT BIOLOGY (2015)
Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion
Nikola Vlahov et al.
CURRENT BIOLOGY (2015)
Identification of Happyhour/MAP4K as Alternative Hpo/Mst-like Kinases in the Hippo Kinase Cascade
Yonggang Zheng et al.
DEVELOPMENTAL CELL (2015)
Crumbs3-Mediated Polarity Directs Airway Epithelial Cell Fate through the Hippo Pathway Effector Yap
Aleksander D. Szymaniak et al.
DEVELOPMENTAL CELL (2015)
Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway
Jung-Soo Mo et al.
NATURE CELL BIOLOGY (2015)
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
Francesca Zanconato et al.
NATURE CELL BIOLOGY (2015)
YAP1 and AR interactions contribute to the switch from androgen-dependent to castration-resistant growth in prostate cancer
Gamze Kuser-Abali et al.
NATURE COMMUNICATIONS (2015)
A basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemness
Tackhoon Kim et al.
NATURE COMMUNICATIONS (2015)
MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway
Zhipeng Meng et al.
NATURE COMMUNICATIONS (2015)
Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis
Hongtan Wu et al.
NATURE COMMUNICATIONS (2015)
Transcriptional Co-repressor Function of the Hippo Pathway Transducers YAP and TAZ
Minchul Kim et al.
CELL REPORTS (2015)
Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase
Biao Ma et al.
NATURE CELL BIOLOGY (2015)
Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP
Fa-Xing Yu et al.
CANCER CELL (2014)
A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
Shi Jiao et al.
CANCER CELL (2014)
YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response
Luca Azzolin et al.
CELL (2014)
Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
Avnish Kapoor et al.
CELL (2014)
KRAS and YAP1 Converge to Regulate EMT and Tumor Survival
Diane D. Shao et al.
CELL (2014)
VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex
Wenjing Zhang et al.
CELL RESEARCH (2014)
PTPN14 Forms a Complex with Kibra and LATS1 Proteins and Negatively Regulates the YAP Oncogenic Function
Kayla E. Wilson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration
Jonathan W. Haskins et al.
SCIENCE SIGNALING (2014)
Energy Stress Regulates Hippo-YAP Signaling Involving AMPK-Mediated Regulation of Angiomotin-like 1 Protein
Michael DeRan et al.
CELL REPORTS (2014)
PTPN14 interacts with and negatively regulates the oncogenic function of YAP
X. Liu et al.
ONCOGENE (2013)
The Tyrosine Phosphatase PTPN14 Is a Negative Regulator of YAP Activity
Chrysiis Michaloglou et al.
PLOS ONE (2013)
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Fa-Xing Yu et al.
CELL (2012)
β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis
Joseph Rosenbluh et al.
CELL (2012)
PTPN14 is required for the density-dependent control of YAP1
Wenqi Wang et al.
GENES & DEVELOPMENT (2012)
Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
Bin Zhao et al.
GENES & DEVELOPMENT (2011)
Angiomotin-like Proteins Associate with and Negatively Regulate YAP1
Wenqi Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Dual Processing of FAT1 Cadherin Protein by Human Melanoma Cells Generates Distinct Protein Products
Elham Sadeqzadeh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Role of YAP/TAZ in mechanotransduction
Sirio Dupont et al.
NATURE (2011)
G protein-coupled receptors: novel targets for drug discovery in cancer
Rosamaria Lappano et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components
Nam-Gyun Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression
Hai Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene
Dawang Zhou et al.
CANCER CELL (2009)
MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation
Maria Praskova et al.
CURRENT BIOLOGY (2008)
TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway
Qun-Ying Lei et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Yap1 phosphorylation by c-AbI is a critical step in selective activation of proapoptotic genes in response to DNA damage
Dan Levy et al.
MOLECULAR CELL (2008)
PML, YAP, and p73 Are Components of a Proapoptotic Autoregulatory Feedback Loop
Eleonora Lapi et al.
MOLECULAR CELL (2008)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
Wnt/β-catenin signaling in development and disease
Hans Clevers
CELL (2006)
Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes
Umut Oezcan et al.
SCIENCE (2006)
Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis
HI Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP
JB Huang et al.
CELL (2005)
WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function
RI Aqeilan et al.
CANCER RESEARCH (2005)
The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA damage
S Strano et al.
MOLECULAR CELL (2005)
The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1
EH Chan et al.
ONCOGENE (2005)
WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus
A Komuro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts
S Wu et al.
CELL (2003)
Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context
C Guerra et al.
CANCER CELL (2003)
Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis
S Basu et al.
MOLECULAR CELL (2003)
Causal relationship between the loss of RUNX3 expression and gastric cancer
QL Li et al.
CELL (2002)
Physical interaction with Yes-associated protein enhances p73 transcriptional activity
S Strano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
